Digipath
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc
Search This Board: 
Last Post: 1/20/2019 1:40:43 PM - Followers: 678 - Board type: Free - Posts Today: 1

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

Digipath
AMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Amarantus Provides 2019 Roadmap 01/07/2019 08:00:00 AM
AMBS News: Coeptis Pharma Enters into Agreement to Acquire Elto Pharma 11/28/2018 07:30:00 AM
PlusOneCoin Top Posts
#128899   JP, are you gonna sit here and tell freegriff 01/15/19 10:10:25 PM
#128903   https://www.nature.com/articles/s42255-018-0023-6 Article / Published: 14 Janua Kgs68 01/16/19 09:05:03 AM
PostSubject
#128357  Sticky Note what are you talking about? JPetroInc 06/16/18 01:00:07 PM
#128940   https://medicalxpress.com/news/2019-01-manf-rejuvenating-factor-parabiosis.html Sapere Aude 01/20/19 01:40:42 PM
#128937   Why would anyone sell for less then .05 sharp63 01/18/19 10:05:49 AM
#128935   he's worked without pay for three years, ten freegriff 01/18/19 08:10:58 AM
#128934   What amazes me the level of incompetence of breezy1 01/18/19 02:11:30 AM
#128932   Thanks I read the road map news and breezy1 01/17/19 02:54:44 PM
#128931   sale was for 7.5 million shares of coeptis freegriff 01/17/19 02:50:12 PM
#128930   319 mm valuation breezy1 01/17/19 02:09:14 PM
#128929   Is it 90million? breezy1 01/17/19 01:46:43 PM
#128928   What will be the price paid for ? “Coeptis breezy1 01/17/19 01:45:36 PM
#128927   The selling has begun . 8 to 1 7Bullet7 01/17/19 01:15:26 PM
#128926   Lol fake patents $ AMBS. zoomboom 01/17/19 12:49:27 PM
#128925   THIS CON IS CAPABLE OF FAKE PRs. newflow 01/17/19 12:41:28 PM
#128924   Selling super dry! News reaction is always a Ryguy008 01/17/19 10:59:58 AM
#128923   Um we havent even had many trades... lol Ryguy008 01/17/19 10:35:51 AM
#128922   New new updated yellow stickies jeffshir 01/17/19 10:03:06 AM
#128921   Huge? Haha. Ya, Huge sell-off for sure. TopKnotchTrades 01/17/19 10:01:13 AM
#128920   More news today! HUGEEE https://www.otcmarkets.com/stock/AMBS/news/MANF-Therapeu Ryguy008 01/17/19 08:22:16 AM
#128919   Zero dilution happening bud. Ryguy008 01/17/19 07:32:54 AM
#128918   Lots of different articles being written on MANF https://www.buckinstitute.org/ Kgs68 01/17/19 07:28:12 AM
#128917   MANF Therapeutics Receives Notices of Allowance Covering MANF zoomboom 01/17/19 07:08:53 AM
#128916   rampant non-stop serial dilution will have you holding JPetroInc 01/17/19 03:49:02 AM
#128915   I just opened my free account on IHUB Space_Invader 01/17/19 03:14:37 AM
#128914   I LOST 100K or more BECAUSE OF THE newflow 01/17/19 12:39:22 AM
#128911   ITS PINK NOW FROM QB newflow 01/16/19 01:29:02 PM
#128910   THE CON CEO HAS $829 CASH ON HAND newflow 01/16/19 01:28:14 PM
#128909   $829 CASH ON HAND BEG FOR MONEY ON newflow 01/16/19 01:26:53 PM
#128908   $AMBS fillings today!https://www.otcmarkets.com/stock/AMBS/disclosure Ryguy008 01/16/19 01:16:13 PM
#128907   It seems to me we are going to mazennnn 01/16/19 01:11:47 PM
#128906   https://www.otcmarkets.com/stock/AMBS/disclosure zoomboom 01/16/19 12:00:06 PM
#128905   Good morning AMBS board!! texas_gal 01/16/19 11:39:54 AM
#128904  Restored hmm wonder where Heinrich Jasper now works... freegriff 01/16/19 09:53:27 AM
#128903   https://www.nature.com/articles/s42255-018-0023-6 Article / Published: 14 Janua Kgs68 01/16/19 09:05:03 AM
#128902   This has way more gas in the tank. Ryguy008 01/16/19 08:03:52 AM
#128901   Sorry but the O/s is maxed and they Ryguy008 01/16/19 07:58:59 AM
#128900   and I think Gerald & the esteemed BOD Sapere Aude 01/16/19 06:10:03 AM
#128899   JP, are you gonna sit here and tell freegriff 01/15/19 10:10:25 PM
#128898   commercialization of exactly what ? JPetroInc 01/15/19 09:01:23 PM
#128895   That’s pretty much the only way ambs moves. itwentdwnhwmch 01/15/19 04:46:46 PM
#128894   con needs money.at the end of the press newflow 01/15/19 04:42:35 PM
#128890   What a joke this thing is. Let me TopKnotchTrades 01/15/19 12:36:29 PM
#128889   I posted on some boards! Hopefully more people texas_gal 01/15/19 10:16:27 AM
#128888   Lots of people continue to sleep on this Ryguy008 01/15/19 09:57:42 AM
#128886   Huge boom! This is ground breaking! Gerald will SidVicious 01/15/19 09:30:59 AM
#128885   $AMBS Boom! Patent approval Notice of allowance https://www.gurufocus.com Ryguy008 01/15/19 09:22:11 AM
#128884   This is YUGE news! this is going to SidVicious 01/15/19 08:25:21 AM
#128883   Banggg fantastic! Chasers to the podium, please Ryguy008 01/15/19 07:43:20 AM
#128882   MANF Therapeutics Receives Notice of Allowance from US zoomboom 01/15/19 07:24:12 AM
#128881   speak to deez nutz Japers freegriff 01/14/19 04:19:17 PM
#128880   speak to the Magic 8 JPetroInc 01/14/19 01:32:51 PM
#128879   No brainer buying at these levels, way undervalued. Ryguy008 01/14/19 10:34:21 AM
PostSubject